Depomed Reports Record Sales in Third Quarter 2015 and Raises Full Year 2015 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
Go back to Depomed Reports Record Sales in Third Quarter 2015 and Raises Full Year 2015 Guidance
November 11, 2015 7:34 AM EST
WallachBeth Capital upgraded DepoMed Inc (NASDAQ: DEPO) from Hold to Buy with a price target of $33.00.
For an analyst ratings summary and ratings history on DepoMed Inc click here. For more ratings news on DepoMed Inc click here.
Shares of DepoMed Inc closed at $21.21 yesterday.
...
More
November 10, 2015 9:25 AM EST
Janney Capital reiterated a Buy rating and $35.00 price target on DepoMed Inc (NASDAQ: DEPO) following the company's 3Q earnings report. DEPO reports $104.9 mln in revenues and non-GAAP adjusted EPS of $0.33, easily beating consensus estimates of $$101.64 mln and non-GAAP adjusted earnings of $0.19 per share.
Analyst... More
November 9, 2015 4:04 PM EST
Depomed (NASDAQ: DEPO) reported Q3 EPS of $0.33, $0.14 better than the analyst estimate of $0.19. Revenue for the quarter came in at $105 million versus the consensus estimate of $101.64 million.
Opportunities for Sustained Growth·
NUCYNTA is strongly positioned...
More
